- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/38 - Halogen atoms or nitro radicals
Patent holdings for IPC class C07D 211/38
Total number of patents in this class: 202
10-year publication summary
|
15
|
16
|
15
|
8
|
18
|
11
|
12
|
19
|
14
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 254 |
9 |
| 3m Innovative Properties Company | 17481 |
7 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 874 |
7 |
| Vividion Therapeutics, Inc. | 44 |
5 |
| Theravance Biopharma R&D IP, LLC | 362 |
4 |
| Grey Wolf Therapeutics Limited | 17 |
4 |
| Dice Molecules Sv, Inc. | 12 |
4 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| Massachusetts Institute of Technology | 10254 |
3 |
| California Institute of Technology | 4037 |
3 |
| Toray Industries, Inc. | 7111 |
3 |
| National Institute of Advanced Industrial Science and Technology | 3794 |
3 |
| The Broad Institute, Inc. | 1979 |
3 |
| ChemoCentryx, Inc. | 361 |
3 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 92 |
3 |
| OPKO Health, Inc. | 44 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 850 |
3 |
| Teijin Pharma Limited | 253 |
3 |
| Teika Pharmaceutical Co., Ltd. | 34 |
3 |
| Toyama Chemical Co., Ltd. | 88 |
3 |
| Other owners | 123 |